Atlas Trials

Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV

Clinical trial NCT02124044 · COMPLETED

Trial details

NCT number
NCT02124044
Sponsor
National Institutes of Health Clinical Center (CC)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-HCV
Start date
2014-02-01
Primary completion
2016-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.